PLAG vs. AIKI, PIRS, AYTU, MTEX, ORGS, AVTX, MHUA, DOMH, NRXS, and NRBO
Should you be buying Planet Green stock or one of its competitors? The main competitors of Planet Green include AIkido Pharma (AIKI), Pieris Pharmaceuticals (PIRS), Aytu BioPharma (AYTU), Mannatech (MTEX), Orgenesis (ORGS), Avalo Therapeutics (AVTX), Meihua International Medical Technologies (MHUA), Dominari (DOMH), NeurAxis (NRXS), and NeuroBo Pharmaceuticals (NRBO). These companies are all part of the "medical" sector.
Planet Green (NYSE:PLAG) and AIkido Pharma (NASDAQ:AIKI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, analyst recommendations, media sentiment, community ranking, dividends and earnings.
AIkido Pharma received 101 more outperform votes than Planet Green when rated by MarketBeat users.
AIkido Pharma has a net margin of 0.00% compared to Planet Green's net margin of -76.86%. AIkido Pharma's return on equity of -18.21% beat Planet Green's return on equity.
0.3% of Planet Green shares are owned by institutional investors. Comparatively, 10.9% of AIkido Pharma shares are owned by institutional investors. 20.7% of Planet Green shares are owned by insiders. Comparatively, 8.6% of AIkido Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
In the previous week, Planet Green had 2 more articles in the media than AIkido Pharma. MarketBeat recorded 3 mentions for Planet Green and 1 mentions for AIkido Pharma. AIkido Pharma's average media sentiment score of 0.67 beat Planet Green's score of 0.39 indicating that AIkido Pharma is being referred to more favorably in the news media.
Planet Green has a beta of -0.42, meaning that its stock price is 142% less volatile than the S&P 500. Comparatively, AIkido Pharma has a beta of 0.93, meaning that its stock price is 7% less volatile than the S&P 500.
AIkido Pharma has lower revenue, but higher earnings than Planet Green. AIkido Pharma is trading at a lower price-to-earnings ratio than Planet Green, indicating that it is currently the more affordable of the two stocks.
Summary
AIkido Pharma beats Planet Green on 9 of the 14 factors compared between the two stocks.
Get Planet Green News Delivered to You Automatically
Sign up to receive the latest news and ratings for PLAG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PLAG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Planet Green Competitors List
Related Companies and Tools
